Lifecore Biomedical, Inc. (LFCR) - מזומנים למניה אחת

סמל תאגידי ולוגו של Lifecore (LFCR)

Lifecore Biomedical relies on a broad pool of B2B partners for sterile injectable manufacturing, which mitigates the risks of individual failures. The cash per share trend visualizes this process, and the 0.60 metric confirms the current level. Complex FDA certification and expertise in biopolymers create a defensive barrier. A steady stream of payments from locked-in clients guarantees predictable cash flow.

LFCR lifecore.com: יתרות מזומנים למניה בטווח 28.04.2023 - 20.11.2026

פילוחים אנליטיים של חברת lifecore.com (LFCR)

- מחיר שוק ויעדי מחיר של אנליסטים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מסכם של החברה:Lifecore Biomedical, Inc.
מוצר מקורי של Lifecore Biomedical

This indicator determines the volume of available liquidity per common share, allowing for an assessment of the issuer's real cash cushion regardless of market volatility. By analyzing the history of cash per share, an investor can see the financial stability of Lifecore Biomedical (LFCR), which is supported by high medical compliance and a steady inflow of free cash flow from long-term contracts with pharma behemoths.